AstraZeneca CEO hails NHS drug price deal but keeps pause on £200m UK investment

February 10, 2026

Pascal Soriot suggests UK-US agreement will not be enough to revive plan to expand Cambridge site

Business live – latest updates

The boss of Britain’s biggest pharmaceutical company has said the government’s recent drug pricing deal is a “very positive step” but is unlikely to unfreeze a paused £200m investment in Cambridge.

AstraZeneca’s chief executive, Pascal Soriot, suggested that a UK-US deal on NHS pricing agreed in December would not be “sufficient” to restart the project to build a research site in the east of England, which was paused in September.

Source: www.theguardian.com

Read full article

Written by: truelightfm

Rate it

Ukraine rallies Europe to block FIFA’s push to end Russia’s football ban

Ukraine is gathering support from European governments to oppose FIFA's moves to end Russia's ban from international football.Source: feeds.skynews.comRead full article

February 10, 2026